Pablo Sanchez to Alemtuzumab
This is a "connection" page, showing publications Pablo Sanchez has written about Alemtuzumab.
Connection Strength
0.205
-
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience. Front Immunol. 2022; 13:864545.
Score: 0.205
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.